A Bioequivalence Study Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05021887 · UNKNOWN

Trial details

NCT number: NCT05021887
Sponsor: Respirent Pharmaceuticals Co Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Bioequivalence

Start date: 2021-08-13
Primary completion: 2021-09-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.